These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 23552923)

  • 1. Sizing up a slow assault on cancer.
    Ledford H
    Nature; 2013 Apr; 496(7443):14-5. PubMed ID: 23552923
    [No Abstract]   [Full Text] [Related]  

  • 2. Skin Reactions to Immune Checkpoint Inhibitors.
    Patel AB; Pacha O
    Adv Exp Med Biol; 2017; 995():175-184. PubMed ID: 28321818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic human monoclonal antibodies against cancer.
    Jarboe J; Gupta A; Saif MW
    Methods Mol Biol; 2014; 1060():61-77. PubMed ID: 24037836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The safety of therapeutic monoclonal antibodies: implications for cancer therapy including immuno-checkpoint inhibitors.
    Demlova R; Valík D; Obermannova R; ZdraŽilová-Dubská L
    Physiol Res; 2016 Dec; 65(Suppl 4):S455-S462. PubMed ID: 28006927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. American Association of Cancer Research Showcases Immunotherapy Advances.
    Brower V
    J Natl Cancer Inst; 2015 Aug; 107(8):. PubMed ID: 26243202
    [No Abstract]   [Full Text] [Related]  

  • 6. Beyond ipilimumab: new approaches target the immunological synapse.
    Garber K
    J Natl Cancer Inst; 2011 Jul; 103(14):1079-82. PubMed ID: 21737695
    [No Abstract]   [Full Text] [Related]  

  • 7. Tumor immunology top 10 list.
    Finn OJ
    Immunol Rev; 2008 Apr; 222():5-8. PubMed ID: 18363991
    [No Abstract]   [Full Text] [Related]  

  • 8. Current status of immunotherapy.
    Suzuki S; Ishida T; Yoshikawa K; Ueda R
    Jpn J Clin Oncol; 2016 Mar; 46(3):191-203. PubMed ID: 26819277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ipilimumab].
    Tokudome T
    Gan To Kagaku Ryoho; 2013 Sep; 40(9):1140-4. PubMed ID: 24047771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PDL-1/PD1 inhibitors: antibody or antinobody?
    Aoun F; Rassy EE; Assi T; Kattan J
    Future Oncol; 2017 Aug; 13(19):1669-1671. PubMed ID: 28831825
    [No Abstract]   [Full Text] [Related]  

  • 11. A New Immunotherapy Drug Creates a Watershed for the Surgical Pathologist's Role in Patient Care.
    Cagle PT; Bernicker EH
    Arch Pathol Lab Med; 2015 Nov; 139(11):1329. PubMed ID: 26516934
    [No Abstract]   [Full Text] [Related]  

  • 12. Trial watch: ipilimumab success in melanoma provides boost for cancer immunotherapy.
    Nat Rev Drug Discov; 2010 Aug; 9(8):584. PubMed ID: 20671754
    [No Abstract]   [Full Text] [Related]  

  • 13. The monoclonal antibody to cytotoxic T lymphocyte antigen 4, ipilimumab (MDX-010), a novel treatment strategy in cancer management.
    Movva S; Verschraegen C
    Expert Opin Biol Ther; 2009 Feb; 9(2):231-41. PubMed ID: 19236253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First-Line Immune Therapy-Implications for Pathologists.
    Miller RA; Cagle PT; Bernicker EH
    Arch Pathol Lab Med; 2016 Aug; 140(8):739-40. PubMed ID: 27472228
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunotherapies in clinical trials: do they demand different evaluation tools?
    Tuma RS
    J Natl Cancer Inst; 2011 May; 103(10):780-1. PubMed ID: 21551417
    [No Abstract]   [Full Text] [Related]  

  • 16. Development of ipilimumab: contribution to a new paradigm for cancer immunotherapy.
    Hoos A; Ibrahim R; Korman A; Abdallah K; Berman D; Shahabi V; Chin K; Canetta R; Humphrey R
    Semin Oncol; 2010 Oct; 37(5):533-46. PubMed ID: 21074069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immuno-oncology moves beyond PD-1.
    Sheridan C
    Nat Biotechnol; 2015 Jul; 33(7):673-5. PubMed ID: 26153987
    [No Abstract]   [Full Text] [Related]  

  • 18. Trial offers early test case for personalized medicine.
    Garber K
    J Natl Cancer Inst; 2009 Feb; 101(3):136-8. PubMed ID: 19176464
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapeutic antibodies against cancer.
    Adler MJ; Dimitrov DS
    Hematol Oncol Clin North Am; 2012 Jun; 26(3):447-81, vii. PubMed ID: 22520975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of monoclonal antibodies as cancer therapy in solid tumors.
    Dienstmann R; Markman B; Tabernero J
    Curr Clin Pharmacol; 2012 May; 7(2):137-45. PubMed ID: 22432839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.